Diagnosis and Management of Acute Exacerbations of COPD – Pharmacology CME
ebmedicine.net
As more and more patients present to the ED with symptoms that suggest an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) –worsening dyspnea, cough and sputum production – emergency clinicians can improve patient comfort and possibly mitigate morbidity and mortality with the right testing and treatment interventions:
- COPD is a clinical diagnosis, but some tests can exclude comorbid conditions
- When to give antibiotics and when to culture
- The SpO2 range to aim for
- ECG findings typical of COPD
- The role of ultrasound
- Oxygen, bronchodilators, corticosteroids, and antibiotics: which ones, and how much?
- Reviewing noninvasive ventilation and intubation options
More than 1.7 million patients per year present to the emergency department requiring treatment for chronic obstructive pulmonary disease (COPD), with about 20% requiring inpatient hospitalization. This costs the United States, directly and indirectly, between $35 and $50 billion each year. The GOLD guidelines, updated in 2016, contain a consensus definition for acute exacerbation of COPD, risk assessment, and evidence-based management strategies.